Author of the publication

Synthetic small-molecule complement inhibitors.

, , and . Current opinion in investigational drugs (London, England : 2000), 5 (11): 1164--1173 (November 2004)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Conformational interconversion in compstatin probed with molecular dynamics simulations., , and . Proteins, 53 (1): 130--141 (October 2003)Thermodynamic studies on the interaction of the third complement component and its inhibitor, compstatin., , and . Journal of Biological Chemistry, 279 (53): 54987--54995 (December 2004)Conformational analysis of compstatin analogues with molecular dynamics simulations in explicit water., , , , and . Journal of molecular graphics & modelling, 26 (2): 571--580 (September 2007)Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3., , and . Molecular Immunology, 39 (10): 557--566 (January 2003)Molecular Mechanism of Biased Ligand Conformational Changes in CC Chemokine Receptor 7., , and . Journal of Chemical Information and Modeling, 56 (9): 1808-1822 (2016)Predicting peptide structures using NMR data and deterministic global optimization., , , and . J. Comput. Chem., 20 (13): 1354-1370 (1999)Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity., , , , , , and . Journal of the American Chemical Society, 125 (28): 8422--8423 (July 2003)Physical methods for structure, dynamics and binding in immunological research., and . Trends in immunology, 25 (12): 700--707 (December 2004)Synthetic small-molecule complement inhibitors., , and . Current opinion in investigational drugs (London, England : 2000), 5 (11): 1164--1173 (November 2004)Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins., , , , and . Journal of Immunology, 174 (4): 2143--2151 (February 2005)